Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06802224 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery

Study acronym: VEGA-2
StatusRecruiting
PhasePhase 4
Started2025-04-01
View on ClinicalTrials.gov ↗

Amendment history

2026-05-20
minor
Study Status, Sponsor/Collaborators, Contacts/Locations v5
Study sites8→10
Collaborators9 to 10 entries
University Health Network, Toronto
2026-03-10
minor
Study Status, Contacts/Locations v4
Study sitescontacts updated at 1 of 8 sites
2026-03-02
minor
Study Status, Contacts/Locations v3
Study sites2→8
2025-04-11
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-03-01→confirmed 2025-04-01
Study sitesdetails revised at 2 of 2 sites
2025-01-30
minor
Study Identification, Study Status, Outcome Measures v1
Primary endpoints1 entry, revised
Acute Kidney InuryInjury (AKI)
Study title-61 characters
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery: A Multicenter Pragmatic Cluster Cross-over Randomized Trial
2025-01-28
minor
Original filing
Low blood pressure, also known as hypotension, is very common during major surgery under general anesthesia. Prolonged or severe hypotension can lead to complications such as kidney injury after surgery that slow down patient recovery. Anesthesiologists commonly administer medications called vasopressors to treat low blood pressure during surgery. These medications help raise the blood pressure back up to a safe range. Two vasopressor medications are commonly used for this purpose: norepinephrine and phenylephrine. Each of these medications has slightly different effects on the heart and blood vessels (cardiovascular system). It remains unknown which of these standard medications is better for treating low blood pressure during surgery. The goal of this clinical trial is to determine which of these two medications is better at preventing injury to the kidneys after major noncardiac surgery as well as other complications such as heart problems. Major surgeries are defined as those lasting at least two hours under general anesthesia. This trial will randomize about ten centers in North America to use either norepinephrine or phenylephrine as the primary medication to treat low blood pressure in adults undergoing major noncardiac surgery. Each hospital will prioritize one of the drugs each month, and the assigned drug will rotate each month at each hospital. No further participant involvement will be required as de-identified data are collected as part of standard medical care.
Trial Details
NCT Number NCT06802224
Lead Sponsor University of California, San Francisco
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Michigan, Henry Ford Health System, University of Washington, University of Texas Southwestern Medical Center, Wake Forest University Health Sciences, University of Virginia, University of Maryland, Duke University, University Health Network, Toronto
Conditions Anesthesia, Surgery With General Anesthesia, Noncardiac Surgery, Hypotension During Surgery, Acute Kidney Injury (AKI), Myocardial Injury After Noncardiac Surgery (MINS), Vasopressor
Enrollment 18,000 participants
Start Date 2025-04-01
Primary Completion 2028-07 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-26